Table 7

Multivariable ORs for VTE, considering adverse events that occurred before a VTE

Adverse eventOR95% CIP value*
Any adverse event13.27510.490 to 16.060<0.001
Surgical adverse event12.3589.559 to 15.156<0.001
 Superficial SSI9.1346.115 to 12.152<0.001
 Deep SSI8.1795.032 to 11.325<0.001
 Organ/Space SSI10.7467.809 to 13.683<0.001
 Superficial wound dehiscence9.1326.129 to 12.136
 Deep wound dehiscence
 Bleeding requiring transfusion12.0099.207 to 14.810<0.001
 Flap failure6.4483.386 to 9.511<0.001
 Nerve injury
Medical adverse event11.7508.957 to 14.543<0.001
 Reintubation10.5977.773 to 13.420<0.001
 Pneumonia9.9317.053 to 12.809<0.001
 Sepsis10.2447.421 to 13.068<0.001
 Septic shock9.1526.292 to 12.012<0.001
 CLABSI9.3286.323 to 12.333<0.001
Clostridium difficile colitis
 UTI9.6166.709 to 12.524<0.001
 Renal failure7.1723.947 to 10.396<0.001
 Renal insufficiency5.4052.120 to 8.6900.001
 Stroke
 Seizure
 Cardiac arrest
 Coma
Reoperation11.4798.668 to 14.290<0.001
Readmission11.7418.931 to 14.551<0.001
  • *Firth logistic regressions to determine the OR of VTE for preceding adverse events. Each regression controls variables of patient age, sex and ASA class. Bolding indicates statistical significance at p<0.05.

  • †Insufficient number of observations for regression analysis.

  • ASA, American Society of Anesthesiologists; CI, confidence interval; CLABSI, central line-associated bloodstream infection; OR, odds ratio; SSI, surgical site infection; UTI, urinary tract infection; VTE, venous thromboembolism.